Concepedia

Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy

Lulu Cui, Jia Huang, Yongtao Zhan, Ni Qiu, Huan Jin, Jia Li, Huiqi Huang, Hongsheng Li

Life Sciences · 2021 · 13 citations · 25 references

DOI

Concepts

References

25

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al. · CA A Cancer Journal for Clinicians · 2018 · 87.7K citations · Full text

, , +16

Incidence and Predictors of Low Dose-Intensity in Adjuvant Breast Cancer Chemotherapy: A Nationwide Study of Community Practices

Gary H. Lyman, David C. Dale, Jeffrey Crawford · Journal of Clinical Oncology · 2003 · 463 citations

, , +16

C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

Yasuo Imai, Minoru Nakane, Kumie Kage et al. · PubMed · 2002 · 441 citations

, , +17

HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials

Alessandra Gennari, Maria Pia Sormani, P. Pronzato et al. · JNCI Journal of the National Cancer Institute · 2007 · 370 citations

, , +13

HER2 and Choice of Adjuvant Chemotherapy for Invasive Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15

Soonmyung Paik · JNCI Journal of the National Cancer Institute · 2000 · 306 citations

, , +16